Condensed Balance Sheets - USD ($)		Sep. 30, 2025	Aug. 12, 2025
Assets:
Current asset – prepaid expenses			$ 35,500
Deferred offering costs		151,502	25,000
Total Assets		151,502	60,500
Liabilities and Shareholder’s (Deficit) Equity:
Accrued offering costs		6,140	25,000
Accrued expenses			16,927
Accounts payable		14,616
Total Liabilities		192,695	52,427
Commitments and Contingencies (Note 7)
Shareholder’s (Deficit) Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital		24,137	24,137
Accumulated deficit		(66,193)	(16,927)
Total Shareholder’s (Deficit) Equity		(41,193)	8,073
Total Liabilities and Shareholder’s (Deficit) Equity		151,502	60,500
Related Party
Liabilities and Shareholder’s (Deficit) Equity:
Promissory note – related party		171,939	10,500
Class A Ordinary Shares
Shareholder’s (Deficit) Equity
Ordinary shares, value
Class B Ordinary Shares
Shareholder’s (Deficit) Equity
Ordinary shares, value	[1],[2]	$ 863	$ 863

[1] Includes an aggregate of up to 1,125,000 Class B ordinary shares, $0.0001 par value subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 6).

[2] On December 8, 2025, through a share capitalization, the Company issued an additional 958,333 founder shares to our sponsor, resulting in our sponsor holding an aggregate of 8,625,000 founder shares. All share amounts and related information have been retroactively restated to reflect the share capitalization (Note 6).